TREA

90692260 - THANOSWITCH

Follow

Information

  • Trademark
  • 90692260
  • Serial Number
    90692260
  • Filing Date
    May 05, 2021
    3 years ago
  • Transaction Date
    December 26, 2023
    a year ago
  • Status Date
    December 25, 2023
    a year ago
  • Published for Opposition Date
    March 28, 2023
    a year ago
  • Location Date
    May 23, 2023
    a year ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    BECHHOFER, YOCHEVED D
  • Attorney Docket Number
    V03252000600
    Attorney Name
    Christina M. Licursi
    Law Office Assigned Location Code
    M50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
THANOSWITCH
Case File Statements
  • GS0051: Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules for medical use, for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine
  • PM0001: THANO SWITCH
  • GS0421: Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others
Case File Event Statements
  • 12/26/2023 - a year ago
    22 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 12/25/2023 - a year ago
    21 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 5/23/2023 - a year ago
    20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/28/2023 - a year ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/28/2023 - a year ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/8/2023 - a year ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/23/2023 - a year ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/7/2023 - a year ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/6/2023 - a year ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/6/2023 - a year ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/4/2023 - 2 years ago
    12 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 8/8/2022 - 2 years ago
    11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/8/2022 - 2 years ago
    10 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/8/2022 - 2 years ago
    9 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/8/2022 - 2 years ago
    8 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/8/2022 - 2 years ago
    7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/8/2022 - 2 years ago
    6 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/11/2022 - 3 years ago
    5 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/11/2022 - 3 years ago
    4 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/11/2022 - 3 years ago
    3 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/6/2022 - 3 years ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/6/2021 - 3 years ago
    1 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS